Drug Profile
Research programme: urinary incontinence therapy - Grunenthal
Alternative Names: Urinary incontinence therapy research programme - GrunenthalLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Grunenthal
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Urinary incontinence
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Urinary-incontinence in Germany
- 24 Jun 2005 Preclinical trials in Urinary incontinence in Germany (unspecified route)